Invasive fungal infections in congenital immunodeficiencies

Clinical Microbiology and Infection

Volumn 16, Issue 9, 2010, Pages 1335-1342

  Antachopoulos, C ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Aspergillus; Candida; Chronic granulomatous disease; Congenital immunodeficiencies; Fungal infections; Review

Indexed keywords

GALACTOMANNAN; GAMMA INTERFERON; ITRACONAZOLE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL DISORDER; DIGEORGE SYNDROME; ENZYME DEFICIENCY; FUNGUS ISOLATION; HUMAN; HYPER IGE SYNDROME; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; LEUKOCYTE ADHESION DEFICIENCY; LIVER ABSCESS; MYCOSIS; MYELOPEROXIDASE DEFICIENCY; NEUTROPENIA; OPPORTUNISTIC INFECTION; OSTEOMYELITIS; PHAGOCYTOSIS; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEVERE COMBINED IMMUNODEFICIENCY; WISKOTT ALDRICH SYNDROME;

AJELLOMYCES; ASPERGILLUS; CANDIDA;

EID: 77956102856     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03289.x     Document Type: Review

References (104)

1. Kumar A, Teuber SS, Gershwin ME. Current perspectives on primary immunodeficiency diseases. Clin Dev Immunol 2006, 13:223-259.
2. Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000, 343:1313-1324.
3. Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 2000, 343:1703-1714.
4. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004, 4:1-23.
5. Mencacci A, Cenci E, Bacci A, Montagnoli C, Bistoni F, Romani L. Cytokines in candidiasis and aspergillosis. Curr Pharm Biotechnol 2000, 1:235-251.
6. van de Veerdonk FL, Gresnigt MS, Kullberg BJ, van der Meer JWM, Joosten LAB, Netea MG. Th17 responses and host defense against microorganisms: an overview. BMB Rep 2009, 42:776-787.
7. Chai LY, van de Veerdonk F, Marijnissen RJ. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology 2010, 130:46-54.
8. Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr 2007, 166:1099-1117.
9. Bianchi M, Hakkim A, Brinkmann V. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 2009, 114:2619-2622.
10. Assari T. Chronic granulomatous disease; fundamental stages in our understanding of CGD. Med Immunol 2006, 5:4.
11. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 2003, 15:578-584.
12. Romani L, Fallarino F, De Luca A. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008, 451:211-215.
13. Winkelstein JA, Marino MC, Johnston RB. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000, 79:155-169.
14. van den Berg JM, van Koppen E, Ahlin A. Chronic granulomatous disease: the European experience. PLoS ONE 2009, 4:e5234.
15. Liese J, Kloos S, Jendrossek V. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000, 137:687-693.
16. Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 1998, 77:345-354.
17. Verweij PE, Varga J, Houbraken J. Emericella quadrilineata as cause of invasive aspergillosis. Emerg Infect Dis 2008, 14:566-572.
18. Mamishi S, Parvaneh N, Salavati A, Abdollahzadeh S, Yeganeh M. Invasive aspergillosis in chronic granulomatous disease: report of 7 cases. Eur J Pediatr 2007, 166:83-84.
19. Almyroudis NG, Holland SM, Segal BH. Invasive aspergillosis in primary immunodeficiencies. Med Mycol 2005, 43(suppl 1):S247-S259.
20. Dotis J, Roilides E. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Int J Infect Dis 2004, 8:103-110.
21. Dennis CG, Greco WR, Brun Y. Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease. Antimicrob Agents Chemother 2006, 50:422-427.
22. Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 2003, 33:453-460.
23. Verweij PE, Weemaes CM, Curfs JH, Bretagne S, Meis JF. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 2000, 38:3900-3901.
24. Siemann M, Koch-Dorfler M, Gaude M. False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay. Mycoses 1998, 41:373-377.
25. Roilides E. Early diagnosis of invasive aspergillosis in infants and children. Med Mycol 2006, 44(suppl):S199-S205.
26. Steinbach WJ, Addison RM, McLaughlin L. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007, 26:558-564.
27. Castagnola E, Furfaro E, Caviglia I. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clin Microbiol Infect 2010, 16:1197-1203.
28. Verweij PE, Mellado E, Melchers WJ. Multiple-triazole-resistant aspergillosis. N Engl J Med 2007, 356:1481-1483.
29. Hodiamont CJ, Dolman KM, Ten Berge IJ, Melchers WJ, Verweij PE, Pajkrt D. Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery. Med Mycol 2009, 47:210-220.
30. Al-Tawfiq JA, Al-Abdely HM. Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma. Med Mycol 2010, 48:537-541.
31. Saulsbury FT. Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin Infect Dis 2001, 32:E137-E139.
32. Briones MA, Josephson CD, Hillyer CD. Granulocyte transfusion: revisited. Curr Hematol Rep 2003, 2:522-527.
33. Ikinciogullari A, Dogu F, Solaz N. Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis. Ther Apher Dial 2005, 9:137-141.
34. Raj R, Kamath SR, Ranjit S, Shankar N, Lakshmanan V. Granulocyte transfusion in children. Indian Pediatr 2009, 46:516-518.
35. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med 1991, 324:509-516. The International Chronic Granulomatous Disease Cooperative Study Group
36. Marciano BE, Wesley R, De Carlo ES. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 2004, 39:692-699.
37. Gallin JI, Alling DW, Malech HL. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003, 348:2416-2422.
38. Reichenbach J, Van de Velde H, De Rycke M. First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching. Pediatrics 2008, 122:e778-e782.
39. Seger RA. Modern management of chronic granulomatous disease. Br J Haematol 2008, 140:255-266.
40. Cohen-Abbo A, Edwards KM. Multifocal osteomyelitis caused by Paecilomyces variotii in a patient with chronic granulomatous disease. Infection 1995, 23:55-57.
41. Wang SM, Shieh CC, Liu CC. Successful treatment of Paecilomyces variotii splenic abscesses: a rare complication in a previously unrecognized chronic granulomatous disease child. Diagn Microbiol Infect Dis 2005, 53:149-152.
42. Williamson PR, Kwon-Chung KJ, Gallin JI. Successful treatment of Paecilomyces variotii infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis 1992, 14:1023-1026.
43. Silliman CC, Lawellin DW, Lohr JA, Rodgers BM, Donowitz LG. Paecilomyces lilacinus infection in a child with chronic granulomatous disease. J Infect 1992, 24:191-195.
44. Phillips P, Forbes JC, Speert DP. Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: response to gamma-interferon plus antifungal chemotherapy. Pediatr Infect Dis J 1991, 10:536-539.
45. Piwoz JA, Stadtmauer GJ, Bottone EJ, Weitzman I, Shlasko E, Cummingham-Rundles C. Trichosporon inkin lung abscesses presenting as a penetrating chest wall mass. Pediatr Infect Dis J 2000, 19:1025-1027.
46. Boltansky H, Kwon-Chung KJ, Macher AM, Gallin JI. Acremonium strictum-related pulmonary infection in a patient with chronic granulomatous disease. J Infect Dis 1984, 149:653.
47. Kenney RT, Kwon-Chung KJ, Waytes AT. Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease. Clin Infect Dis 1992, 14:235-242.
48. Santos PE, Piontelli E, Shea YR. Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease. Med Mycol 2006, 44:749-753.
49. Abinun M, Wright C, Gould K, Flood TJ, Cassidy J. Absidia corymbifera in a patient with chronic granulomatous disease. Pediatr Infect Dis 2007, 26:1167-1168.
50. Marques AR, Kwon-Chung KJ, Holland SM, Turner ML, Gallin JI. Suppurative cutaneous granulomata caused by Microascus cinereus in a patient with chronic granulomatous disease. Clin Infect Dis 1995, 20:110-114.
51. Sutton DA, Thompson EH, Rinaldi MG. Identification and first report of Inonotus (Phellinus) tropicalis as an etiologic agent in a patient with chronic granulomatous disease. J Clin Microbiol 2005, 43:982-987.
52. Roilides E, Sigler L, Bibashi E, Katsifa H, Flaris N, Panteliadis C. Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J Clin Microbiol 1999, 37:18-25.
53. Shigemura T, Agematsu K, Yamazaki T. Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease. Infection 2009, 37:469-473.
54. Vinh DC, Shea YR, Sugui JA. Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis 2009, 49:102-111.
55. Hipolito E, Faria E, Alves AF. Alternaria infectoria brain abscess in a child with chronic granulomatous disease. Eur J Clin Microbiol Infect Dis 2009, 28:377-380.
56. Cramer R, Soranzo MR, Dri P. Incidence of myeloperoxidase deficiency in an area of northern Italy: histochemical, biochemical and functional studies. Br J Haematol 1982, 51:81-87.
57. Parry MF, Root RK, Metcalf JA, Delaney KK, Kaplow LS, Richar WJ. Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med 1981, 95:293-301.
58. Cech P, Stalder H, Widmann JJ, Rohner A, Miescher PA. Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess. Am J Med 1979, 66:149-153.
59. Chiang AK, Chan GC, Ma SK, Ng YK, Ha SY, Lau YL. Disseminated fungal infection associated with myeloperoxidase deficiency in a premature neonate. Pediatr Infect Dis J 2000, 19:1027-1029.
60. Kalinski T, Jentsch-Ullrich K, Fill S, König B, Costa SD, Roessner A. Lethal candida sepsis associated with myeloperoxidase deficiency and pre-eclampsia. APMIS 2007, 115:875-880.
61. Zeidler C. Congenital neutropenias. Hematology 2005, 10(suppl 1):306-311.
62. Zeidler C, Welte K, Barak Y. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000, 95:1195-1198.
63. Smego RA, Devoe PW, Sampson HA, Perfect JR, Wilfert CM, Buckley RH. Candida meningitis in two children with severe combined immunodeficiency. J Pediatr 1984, 104:902-904.
64. Yin EZ, Frush DP, Donnelly LF, Buckley RH. Primary immunodeficiency disorders in pediatric patients: clinical features and imaging findings. AJR Am J Roentgenol 2001, 176:1541-1552.
65. Yoshihara T, Morimoto A, Nakauchi S. Successful transplantation of haploidentical CD34+ selected bone marrow cells for an infantile case of severe combined immunodeficiency with Aspergillus pneumonia. Pediatr Hematol Oncol 2002, 19:439-443.
66. Kobayashi S, Murayama S, Tatsuzawa O. X-linked severe combined immunodeficiency (X-SCID) with high blood levels of immunoglobulins and Aspergillus pneumonia successfully treated with micafangin followed by unrelated cord blood stem cell transplantation. Eur J Pediatr 2007, 166:207-210.
67. Lau YL, Yuen KY, Lee CW, Chan CF. Invasive Acremonium falciforme infection in a patient with severe combined immunodeficiency. Clin Infect Dis 1995, 20:197-198.
68. Bakir M, Cerikcioglu N, Tirtir A, Berrak S, Ozek E, Canpolat C. Pichia anomala fungaemia in immunocompromised children. Mycoses 2004, 47:231-235.
69. Marcinkowski M, Bauer K, Stoltenburg-Didinger G, Vogel M, Versmold H. Fatal aspergillosis with brain abscesses in a neonate with DiGeorge syndrome. Pediatr Infect Dis J 2000, 19:1214-1216.
70. Sergi C, Serpi M, Muller-Navia J. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11. Pathologica 1999, 91:166-172.
71. Winkelstein JA, Marino MC, Ochs H. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003, 82:373-384.
72. Lee MY, Chung JH, Shin JH. Lymphonodular cryptococcosis diagnosed by fine needle aspiration cytology in hyper-IgM syndrome. A case report. Acta Cytol 2001, 45:241-244.
73. Iseki M, Anzo M, Yamashita N, Matsuo N. Hyper-IgM immunodeficiency with disseminated cryptococcosis. Acta Paediatr 1994, 83:780-782.
74. Hostoffer RW, Berger M, Clark HT, Schreiber JR. Disseminated Histoplasma capsulatum in a patient with hyper IgM immunodeficiency. Pediatrics 1994, 94:234-236.
75. Imai K, Morio T, Zhu Y. Clinical course of patients with WASP gene mutations. Blood 2004, 103:456-464.
76. Salzer U, Grimbacher B. Common variable immunodeficiency: the power of co-stimulation. Semin Immunol 2006, 18:337-346.
77. Kane S, Brasitus T. Histoplasmosis capsulatum as a cause of lower gastrointestinal bleeding in common variable immunodeficiency. Dig Dis Sci 2000, 45:2133-2135.
78. Rachid A, Rezende LS, de Moura SF, Loffy PC, Magalhaes FL. A case study of disseminated histoplasmosis linked to common variable immunodeficiency. Braz J Infect Dis 2003, 7:268-272.
79. Couch JR, Romyg DA. Histoplasma meningitis with common variable hypogammaglobulinemia. Neurol Neurocir Psiquiatr 1977, 18:403-412.
80. Tinelli M, Zambelli A, Cavanna C, Michelone G. Pulmonary aspergillosis in a case of humoral immunodeficiency. Microbiologica 1987, 10:235-240.
81. Trachana M, Roilides E, Gompakis N, Kanellopoulou K, Mpantouraki M, Kanakoudi-Tsakalidou F. Case report. Hepatic abscesses due to Aspergillus terreus in an immunodeficient child. Mycoses 2001, 44:415-418.
82. Lin WC, Dai YS, Tsai MJ, Huang LM, Chiang BL. Systemic Penicillium marneffei infection in a child with common variable immunodeficiency. J Formos Med Assoc 1998, 97:780-783.
83. Minegishi Y. Hyper-IgE syndrome. Curr Opin Immunol 2009, 21:487-492.
84. Heimall J, Freeman A, Holland SM. Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol 2010, 38:32-38.
85. Holland SM, DeLeo FR, Elloumi HZ. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007, 18:1608-1619.
86. Borges WG, Augustine NH, Hill HR. Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome. J Pediatr 2000, 136:176-180.
87. Chehimi J, Elder M, Greene J. Cytokine and chemokine dysregulation in hyper-IgE syndrome. Clin Immunol 2001, 100:49-56.
88. Netea MG, Kullberg BJ, van der Meer JW. Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome. Eur J Clin Invest 2005, 35:718-721.
89. Ma CS, Chew GY, Simpson N. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008, 205:1551-1557.
90. Woellner C, Gertz EM, Schäffer AA. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol 2010, 125:424-432.
91. Grimbacher B, Holland SM, Gallin JI. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N Engl J Med 1999, 340:692-702.
92. Haslett RS, Moriarty AP, Vijayadurai P, McGalliard JN, Chandna A. Candida endophthalmitis in Job syndrome. Arch Ophthalmol 1996, 114:617-618.
93. Yates AB, Mehrotra D, Moffitt JE. Candida endocarditis in a child with hyperimmunoglobulinemia E syndrome. J Allergy Clin Immunol 1997, 99:770-772.
94. Yilmaz E. Disseminated pulmonary candidiasis complicating hyperimmunoglobulin E (Job's) syndrome. J Thorac Imaging 2004, 19:48-51.
95. Hutto JO, Bryan CS, Greene FL, White CJ, Gallin JI. Cryptococcosis of the colon resembling Crohn's disease in a patient with the hyperimmunoglobulinemia E-recurrent infection (Job's) syndrome. Gastroenterology 1988, 94:808-812.
96. Garty BZ, Wolach B, Ashkenazi S, Weismart Y, Rachmel A, Nitzan M. Cryptococcal meningitis in a child with hyperimmunoglobulin E syndrome. Pediatr Allergy Immunol 1995, 6:175-177.
97. Steiner SJ, Kleiman MB, Corkins MR, Christenson JC, Wheat LJ. Ileocecal histoplasmosis simulating Crohn disease in a patient with hyperimmunoglobulin E syndrome. Pediatr Infect Dis J 2009, 28:744-746.
98. Hall RA, Salhany KE, Lebel E, Bavaria JE, Kaiser LR. Fungal pulmonary abscess in an adult secondary to hyperimmunoglobulin E (Job's) syndrome. Ann Thorac Surg 1995, 59:759-761.
99. Santambrogio L, Nosotti M, Pavoni G, Harte M, Pietogrande MC. Pneumatocele complicated by fungal lung abscess in Job's syndrome. Successful lobectomy with the aid of videothoracoscopy. Scand Cardiovasc J 1997, 31:177-179.
100. van der Meer JW, Bont L, Verhage J. Aspergillus infection in patients with hyperimmunoglobulin E syndrome. Clin Infect Dis 1998, 27:1337.
101. Wolach B, Eliakim A, Gottesman G, Yellin A. Pulmonary aspergillosis in a child with hyperimmunoglobulin E syndrome. Clin Infect Dis 1998, 26:204-205.
102. Vinh DC, Sugui JA, Hsu AP, Freeman AF, Holland SM. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol 2010, 125:1389-1390.
103. Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005, 41:e38-e41.
104. Moraes-Vasconcelos D, Grumach AS, Yamaguti A. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the beta1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis 2005, 41:e31-e37.